Response to Comment on Herring et al. Metabolic Effects of an SGLT2 In…
작성자 채식영양
작성일 21-01-01 00:00
조회 0
댓글 0
본문
RA. Herring, F. Shojaee-Moradie, R. Garesse, M. Stevenage, N. Jackson, BA. Fielding, A. Mendis, S. Johnsen, AM. Umpleby, M. Davies, et al. (2021). Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136. Diabetes care, 44(3), e61. https://doi.org/10.2337/dci20-0072
댓글목록 0
등록된 댓글이 없습니다.
